Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance
NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Connecticut on behalf of all persons or entities who purchased or otherwise acquired GeneDx Holdings Corp. (“WGS” or the “Company”) (NASDAQ: WGS) securities between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”).
MONTREAL, June 05, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health”, or the “Company”) announces that, further to its press release dated June 2, 2026, the Autorité des marchés financiers, as the Company’s principal regulator, has granted a management cease trade order (the “MCTO”) under National Policy 12-203 – Management Cease Trade Orders.
LITTLE ROCK, Ark., June 05, 2026 (GLOBE NEWSWIRE) -- Uniti Group Inc. (the “Company,” “Uniti,” or “we”) (Nasdaq: UNIT) today announced that Kinetic ABS Issuer LLC, a limited-purpose, bankruptcy remote subsidiary of Uniti (the “Issuer”), has priced its offering of $1,140,710,000 aggregate principal amount of secured fiber network revenue term notes, consisting of $805,210,000 5.834% Series 2026-2, Class A-2 term notes, $134,200,000 6.224% Series 2026-2, Class B term notes and $201,300,000 7.536% Series 2026-2, Class C term notes, each with an anticipated repayment date in June 2033 (collectively, the “Notes”). Collectively, the Notes have a weighted average coupon rate of approximately 6.180%. The Notes are expected to be secured by certain residential fiber network assets and related customer agreements in the States of Texas, Arkansas, Kentucky, Ohio, Georgia, Iowa, Alabama, Florida, North Carolina and Oklahoma. Each of the Issuer and its direct parent entity and subsidiaries are designated as “unrestricted subsidiaries” under Uniti’s credit agreement and the indentures governing its outstanding senior notes. The offering is expected to close on July 15, 2026.
SHANGHAI, June 4, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently developed innovative...
Fully amortizing project financing due 2042; non-recourse to Hut 8 Corp.MIAMI, June 4, 2026 /PRNewswire/ -- Hut 8 Corp. (Nasdaq, TSX: HUT) ("Hut 8" or...
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Badger Meter (BMI) To Contact Him Directly To Discuss Their Options
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE IN THIS STOCK EXCHANGE RELEASE BELOW. Series 1 tranche 1 offering of UAB „Atsinaujinančios energetikos investicijos“ notes under the EUR 25 million Bonds Programme is extended until 11-06-2026: Closed – End Investment Company Intended for Informed Investors UAB “Atsinaujinančios energetikos investicijos” (hereinafter, the “Company”) is extending its public offering of series 1 tranche 1 EUR 2026/2027 Notes (ISIN LT000013780, hereinafter the “Notes”) until 11 June 2026, moving forward also the issue date of the Notes to 15 June 2026 and their maturity term to 15 July 2027. The Notes are being issued under the EUR 25 million Bond Programme. The base prospectus of the programme (hereinafter, the “Prospectus”) was approved by the Bank of Lithuania on 18 May 2026 and announced by the Company. According to the final terms of the series 1 tranche 1, approved by the Company (hereinafter, the “Final Terms”, amended terms are attached, together with the Issue Specific Summary and translations thereof into Lithuanian, Latvian and Estonian), the Company is planning to issue up to EUR 5 million of nominal value Notes maturing on 15 July 2027 to investors in Lithuania, Latvia and Estonia. Summary of the main issue terms: Series 1 tranche 1 size: up to EUR 5,000,000 Denomination: EUR 1,000 Issue price of the Note: EUR 1,000 Interest rate: 9% Subscription period: from 20 May 2026 to 11 June 2026 2:30 pm Vilnius time Settlement and issue date: 15 June 2026 Maturity date: 15 July 2027 Investors wishing to submit a subscription order must contact their brokerage company. The investors, having provided their orders for participation in the offering, should not do anything additionally and their orders are valid, unless they would like to withdraw them, as indicated in the final terms.